Latest Breaking News On - Company specific intellectual property - Page 1 : comparemela.com

/PRNewswire/ The "Current Research & Development Status of Chimeric Antigen Receptor (CAR) T-Cell Therapy" report has been added to ResearchAndMarkets.com s.

United statesLaura woodBarriers to researchCompany specific intellectual propertyFormula pharmaceuticals incGilead sciences incCelgene corpTakeda pharmaceuticalsProduct developmentPuretech healthProtheragen incAbbvie incJuno therapeutics incBristol myers squibbCar therapy developmentBellicum pharmaceuticals inc